Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Incidence of Multiple Sclerosis in the General Population in the Netherlands, 1996-2008.
European Medicines Agency Validates Marketing Authorisation Application for ZINBRYTA™ (Daclizumab High-Yield Process) for Treatment of MS
Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial.
Autologous T Cell Vaccine (TCV) for Multiple Sclerosis (TERMS)
Early phenotypic asymmetry of sister oligodendrocyte progenitor cells after mitosis and its modulation by aging and extrinsic factors.
Progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukaemia treated with alemtuzumab.
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.
The causal cascade to multiple sclerosis: a model for MS pathogenesis.
Nitrous oxide induced myeloneuropathy: a case report.
Pediatric Multiple Sclerosis.
Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.
Anatomical Brain Networks on the Prediction of Abnormal Brain States.
CCR2+CCR5+ T Cells Producing Matrix Metalloproteinase-9 and Osteopontin in the Pathogenesis of Multiple Sclerosis.
The role of interleukin-6 signaling in nervous tissue.
Ustekinumab approved for psoriatic arthritis in US, Europe
Neurocardiogenic Pulmonary Oedema: Initial Presentation of Multiple Sclerosis.
Mycovirus-like DNA virus sequences from cattle serum and human brain and serum samples from multiple sclerosis patients.
The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Construct Validity, Responsiveness, and Interpretation.
Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response.
MRI mean diffusivity detects widespread brain degeneration in multiple sclerosis.
Four different synthetic peptides of proteolipid protein induce a distinct antibody response in MP4-induced experimental autoimmune encephalomyelitis.
Scoring treatment response in patients with relapsing multiple sclerosis.
Expanded functional coupling of subcortical nuclei with the motor resting-state network in multiple sclerosis.
Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis.
18F-FDG PET Detects Inflammatory Infiltrates in Spinal Cord Experimental Autoimmune Encephalomyelitis Lesions.
Pages
« first
‹ previous
…
186
187
188
189
190
191
192
193
194
…
next ›
last »